Editorial: Advanced therapeutic delivery for the management of chronic respiratory diseases

• Keshav Raj Paudel,
• Dinesh Kumar Chellappan,
• Ronan MacLoughlin,
• Ronan MacLoughlin,
• Ronan MacLoughlin,
• Terezinha de Jesus Andreoli Pinto,
• Kamal Dua,
• Kamal Dua,
• Philip M. Hansbro

Affiliations

Keshav Raj Paudel

Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia

Dinesh Kumar Chellappan

Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, SGR, Malaysia

Ronan MacLoughlin

Research and Development, Science and Emerging Technologies, Aerogen Limited, Galway Business Park, Galway, Ireland

Ronan MacLoughlin

School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland

Ronan MacLoughlin

School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, Ireland

Terezinha de Jesus Andreoli Pinto

Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil

Kamal Dua

Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia

Kamal Dua

Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, Australia

Philip M. Hansbro

Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, Australia